Life-long tailoring of management for patients with hypertrophic cardiomyopathy

Independent Assessment of the European Society of Cardiology Sudden Death Risk Model for Hypertrophic Cardiomyopathy

(2015) Barry J. Maron et al.   AMERICAN JOURNAL OF CARDIOLOGY

Genetic advances in sarcomeric cardiomyopathies: state of the art

(2015) C. Y. Ho et al.   CARDIOVASCULAR RESEARCH

Research priorities in sarcomeric cardiomyopathies

(2015) J. van der Velden et al.   CARDIOVASCULAR RESEARCH

Defining phenotypes and disease progression in sarcomeric cardiomyopathies: contemporary role of clinical investigations

(2015) I. Olivotto et al.   CARDIOVASCULAR RESEARCH

Targets for therapy in sarcomeric cardiomyopathies

(2015) J. C. Tardiff et al.   CARDIOVASCULAR RESEARCH

Validation of the 2014 European Society of Cardiology Guidelines Risk Prediction Model for the Primary Prevention of Sudden Cardiac Death in Hypertrophic Cardiomyopathy

(2015) Pieter A. Vriesendorp et al.   Circulation-Arrhythmia and Electrophysiology

New Perspectives on the Prevalence of Hypertrophic Cardiomyopathy

(2015) Christopher Semsarian et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Diltiazem Treatment for Pre-Clinical Hypertrophic Cardiomyopathy Sarcomere Mutation Carriers

(2015) Carolyn Y. Ho et al.   JACC-Heart Failure

Significance of Sarcomere Gene Mutations Analysis in the End-Stage Phase of Hypertrophic Cardiomyopathy

(2014) Elena Biagini et al.   AMERICAN JOURNAL OF CARDIOLOGY

Gene-specific increase in the energetic cost of contraction in hypertrophic cardiomyopathy caused by thick filament mutations

(2014) E. Rosalie Witjas-Paalberends et al.   CARDIOVASCULAR RESEARCH

Genotype-Positive Status in Patients With Hypertrophic Cardiomyopathy Is Associated With Higher Rates of Heart Failure Events

(2014) Q. Li et al.   Circulation-Cardiovascular Genetics

Impact of Adverse Left Ventricular Remodeling on Sudden Cardiac Death in Patients With Hypertrophic Cardiomyopathy

(2014) Pieter A. Vriesendorp et al.   CLINICAL CARDIOLOGY

Myotonic dystrophy: time for evidence-based therapy

(2014) Perry Elliott   EUROPEAN HEART JOURNAL

2014 ESC/ESA Guidelines on non-cardiac surgery: cardiovascular assessment and management

(2014)   EUROPEAN HEART JOURNAL

Novel genotype–phenotype associations demonstrated by high-throughput sequencing in patients with hypertrophic cardiomyopathy

(2014) Luis R Lopes et al.   HEART

Hypertrophic Cardiomyopathy

(2014) Barry J. Maron et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

New ESC guidelines on hypertrophic cardiomyopathy: new insights in invasive treatment?

(2014) E. E. van der Wall   Netherlands Heart Journal

Mutations in MYH7 reduce the force generating capacity of sarcomeres in human familial hypertrophic cardiomyopathy

(2013) E. Rosalie Witjas-Paalberends et al.   CARDIOVASCULAR RESEARCH

Perturbed Length-Dependent Activation in Human Hypertrophic Cardiomyopathy With Missense Sarcomeric Gene Mutations

(2013) Vasco Sequeira et al.   CIRCULATION RESEARCH

Atrial fibrillation and thromboembolism in patients with hypertrophic cardiomyopathy: systematic review

(2013) Oliver P Guttmann et al.   HEART

ENerGetIcs in hypertrophic cardiomyopathy: traNslation between MRI, PET and cardiac myofilament function (ENGINE study)

(2013) A. Güçlü et al.   Netherlands Heart Journal

Sarcomere Gene Mutations Are Associated With Increased Cardiovascular Events in Left Ventricular Hypertrophy

(2013) Takashi Fujita et al.   JACC-Heart Failure

Myofilament Ca Sensitization Increases Cytosolic Ca Binding Affinity, Alters Intracellular Ca Homeostasis, and Causes Pause-Dependent Ca-Triggered Arrhythmia

(2012) Tilmann Schober et al.   CIRCULATION RESEARCH

Patterns of Disease Progression in Hypertrophic Cardiomyopathy

(2012) Iacopo Olivotto et al.   Circulation-Heart Failure

Myofilament Protein Gene Mutation Screening and Outcome of Patients With Hypertrophic Cardiomyopathy

(2012) Iacopo Olivotto et al.   MAYO CLINIC PROCEEDINGS

Long-Term Outcomes in Hypertrophic Cardiomyopathy Caused by Mutations in the Cardiac Troponin T Gene

(2011) Ferdinando Pasquale et al.   Circulation-Cardiovascular Genetics

Manifest disease, risk factors for sudden cardiac death, and cardiac events in a large nationwide cohort of predictively tested hypertrophic cardiomyopathy mutation carriers: determining the best cardiological screening strategy

(2011) I. Christiaans et al.   EUROPEAN HEART JOURNAL

Carriers of the hypertrophic cardiomyopathy MYBPC3 mutation are characterized by reduced myocardial efficiency in the absence of hypertrophy and microvascular dysfunction

(2011) Stefan A.J. Timmer et al.   EUROPEAN JOURNAL OF HEART FAILURE

2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy

(2011) Bernard J. Gersh et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Microvascular Function Is Selectively Impaired in Patients With Hypertrophic Cardiomyopathy and Sarcomere Myofilament Gene Mutations

(2011) Iacopo Olivotto et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Founder mutations in hypertrophic cardiomyopathy patients in the Netherlands

(2011) I. Christiaans* et al.   Netherlands Heart Journal

Myocardial Fibrosis as an Early Manifestation of Hypertrophic Cardiomyopathy

(2010) Carolyn Y. Ho et al.   NEW ENGLAND JOURNAL OF MEDICINE

Diastolic Abnormalities as the First Feature of Hypertrophic Cardiomyopathy in Dutch Myosin-Binding Protein C Founder Mutations

(2009) Michelle Michels et al.   JACC-Cardiovascular Imaging